ARTELAC

This brand name is authorized in Estonia, Finland, France, Germany, Ireland, Lithuania, Netherlands, Poland, Tunisia, UK.

Active ingredients

The drug ARTELAC contains one active pharmaceutical ingredient (API):

1	Hypromellose UNII 3NXW29V3WO - HYPROMELLOSE, UNSPECIFIED
	Read more about Hypromellose

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ARTELAC Eye drops, solution	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01XA20	Artificial tears and other indifferent preparations	S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02726184, 04348183, 04348208, 07617583, 07617614, 11123898, 11123906, 12464087, 12464093, 13837627, 13837633
EE	Ravimiamet	1038136
FI	Lääkealan turvallisuus- ja kehittämiskeskus	034460, 104441, 418896, 535015
FR	Base de données publique des médicaments	65042132
GB	Medicines & Healthcare Products Regulatory Agency	125399, 201640, 299780, 299781, 37774
IE	Health Products Regulatory Authority	14277, 14283, 14296, 19310, 19311, 19312, 19314
LT	Valstybinė vaistų kontrolės tarnyba	1013316
NL	Z-Index G-Standaard	15642089, 15659666
NL	Z-Index G-Standaard, PRK	96385, 96393
PL	Rejestru Produktów Leczniczych	100199620, 100294530, 100299993, 100333230
TN	Direction de la Pharmacie et du Médicament	2743011